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I 
INTRODUCTION 
The legal status and regulation of economic transactions does not depend 
only on considerations about their economic efficiency, but also on the societal 
support for a particular exchange to occur through a market (if at all). Widely 
held concerns that the individuals engaging in certain transactions may be 
exploited or unduly influenced; that the terms of trade may not be fair; or that 
some transactions violate human dignity, the sanctity of life, or traditional 
institutions; may lead a society to prohibit certain trades.1 These principles may 
represent sacred values that take priority over material considerations and 
contribute to defining common identities or a collective conscience that allows 
even complex societies to be tied together.2 Alvin Roth defines as “repugnant” 
those transactions that third parties wish to prohibit even if the underlying 
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 1.  See DEBRA SATZ, WHY SOME THINGS SHOULD NOT BE FOR SALE: THE MORAL LIMITS OF 
MARKETS 94–98 (Samuel Freeman ed., 2010) (listing four primary indicators of noxious markets: 
extremely harmful outcomes for participants or third parties, extremely harmful outcomes for society, 
highly asymmetric knowledge on the part of participants, and extreme vulnerabilities of transacting 
parties).  
 2.  See EMILE DURKHEIM, THE DIVISION OF LABOR IN SOCIETY 38–39 (Anthony Giddens ed., 
W.D. Halls trans., 1984) (arguing that society’s shared moral values create a “collective consciousness,” 
and acts are considered criminal when they offend this shared consciousness).  
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exchanges may be beneficial for the parties directly involved.3 
Examples of transactions that raise or have raised moral concerns often 
leading to their prohibition include prostitution, same-sex marriage, indentured 
servitude, and markets for human organs for transplantation.4 As one considers 
this (incomplete) list of examples, one observation that emerges is that the legal 
treatment of several of these transactions has changed over time in many 
countries. For instance, same-sex marriage, which until recently was nearly 
universally prohibited because it was regarded as in conflict with religious and 
traditional values, is now legal in several countries.5 Additionally, countries that 
otherwise share many similarities in terms of social structure, level of economic 
development, and historical and cultural roots treat certain transactions 
differently. For example, prostitution is legal in Germany but illegal in France, 
and commercial surrogacy is legal in several jurisdictions in the United States6 
but illegal in Canada.7 
These legislative choices raise several questions as to whether the different 
legal treatments of certain transactions actually reflect different levels of societal 
support for those activities across countries, and if so, why. Moreover, seeming 
inconsistencies introduce additional challenges to our understanding of what 
explains support for, or opposition to, morally contentious transactions. This 
article will focus on one such apparent inconsistency: the case of plasma 
donations in Canada and the United States. The United States allows payments 
for plasma donors and the establishment of for-profit plasma centers. In most 
provinces of Canada, in contrast, payments to plasma donors are illegal. 
Canadian policy makers justify the ban on compensation on the basis of moral 
considerations and on concerns regarding the safety of plasma collected from 
paid donors. However, Canada relies on imported plasma from American paid 
donors to meet its need for plasma-derived therapies. For example, 
approximately 83% of immunoglobulin, which is used in Canada (and elsewhere) 
to treat several immune, blood and neurological disorders, is made from plasma 
imported from American for-profit plasma centers.8 
Evidence about the degree of social support (or disapproval) for morally 
controversial activities is scant. Even less evidence is available regarding whether 
the social support is general or country specific; for example, whether the moral 
 
 3.  See Alvin E. Roth, Repugnance as a Constraint on Markets, 21 J. ECON. PERSP. 37, 38 (2007). 
 4.  Id. at 39. 
 5.  Gay Marriage Around the World, PEW RES. CTR. (Aug. 8, 2017), http://www.pewforum.org/ 
2017/08/08/gay-marriage-around-the-world-2013/ [https://perma.cc/2VRD-9D3S].  
 6.  See Kimberly D. Krawiec, Altruism and Intermediation in the Market for Babies, 66 WASH. & 
LEE L. REV. 203, 225 (2009) (“Some states, either through statute or court decisions, take approaches 
relatively friendly to commercial surrogacy arrangements, for example, by analyzing the parties’ intent 
at the time of the contract.”). 
 7.  Assisted Human Reproduction Act, S.C. 2004, c. 2 (Can.).  
 8.  Our Commitment to Increasing Plasma Sufficiency in Canada, CAN. BLOOD SERV., 
https://blood.ca/en/blood/plasma-sufficiency [https://perma.cc/CZ7C-YZZX] (last visited Mar. 1, 2018). 
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opposition that a society may have toward a certain trade refers only to allowing 
that trade in that same country, or everywhere. In particular, individuals may 
display some form of “moral NIMBY-ism”; that is, they may wish to reap the 
benefits from a contested transaction (compensated plasma donation) while 
outsourcing the moral costs of it. Thus, with specific reference to the case of 
plasma donations in Canada, this article asks the following questions: 
• How prevalent is the opposition to compensating plasma donors in 
Canada? 
• What are the main reasons for and against payments? What is the 
relative importance of moral concerns, of concerns regarding safety, 
and of considerations about the importance of guaranteeing a 
sufficient supply to cover medical needs? 
• Are Canadians opposed to paying all plasma donors, or just Canadian 
plasma donors? 
• Do the majority of Canadians exhibit “consequentialist” preferences 
(that is, considerations about the practical impacts of allowing 
payments are important to their attitudes toward payments), or 
“deontological” preferences (meaning their opposition to 
compensating plasma donors reflects a “sacred” value that cannot be 
sacrificed)? 
We conducted a randomized survey experiment with a representative sample 
of 826 Canadian residents. In the survey, respondents were randomly assigned to 
express their opinion in favor or against compensating plasma donors in one of 
three countries: Canada, the United States, or Australia. Similar to Canada, 
compensation to plasma donors is not allowed in Australia, and Australia also 
relies on imported plasma to satisfy its domestic needs.9 Next, according to 
whether the subjects were in favor of or against paying plasma donors, we asked 
how much the respondents agreed with a set of possible motivations for their 
position. The sentences that expressed these motivations stressed the morality of 
allowing or not allowing payments, the risk of attracting donors with 
transmittable diseases if payments were legal, and the importance (or lack 
thereof) of guaranteeing a sufficient domestic supply. By asking a representative 
sample from one country about support for payments in their own country or 
elsewhere, we can determine whether attitudes are general or specific to a 
person’s country of residence. The additional questions about the individuals’ 
motives behind their stances further help to identify not only the differential 
relevance of these motives, but also the weight assigned to them when referring 
to one’s own country as opposed to other countries. 
Part II provides details on plasma uses and collection in Canada, Australia, 
and the United States. Part III describes our experimental design. Part IV 
 
 9.  Robert Slonim, Carmen Wang & Ellen Garbarino, The Market for Blood, 28 J. ECON. PERSP. 
177, 185 (2014). 
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presents our results, and Part V draws conclusions. 
II 
INSTITUTIONAL DETAILS 
A. Plasma Uses And Plasma Donation 
Plasma is the liquid part of blood that remains after removing red blood cells, 
white blood cells, platelets, and other cellular components.10 It consists of water, 
salts, enzymes, antibodies and other proteins (such as albumin, fibrinogen, and 
globulins), and it performs several functions, including clotting blood and fighting 
infections. 
Plasma is used for direct transfusion. It is also used in the production 
of therapies to treat people with chronic diseases and disorders such as primary 
immunodeficiency, hemophilia and genetic lung disease, and in the treatment of 
trauma, burns and shock. Source plasma is plasma that is collected from healthy, 
voluntary donors through a process called plasmapheresis and is used for further 
manufacturing into final therapies (a process called fractionation).11 Recovered 
plasma is collected through whole blood donation in which plasma is separated 
from its cellular components. Recovered plasma may also be used for 
fractionation. Producing all of these therapies requires a large number of plasma 
donations. For example, the annual treatment of one single patient with 
hemophilia requires 1,200 plasma donations.12 
During a source plasma donation, blood is drawn from one arm and 
channeled through an automated machine that collects the plasma and returns 
the remaining blood components (white blood cells, red blood cells, and 
platelets) to the donor. It typically takes between one and three hours to donate 
source plasma. 
Stringent regulations are in place for the screening and testing of plasma 
donors. Moreover, the manufacturing process for plasma products includes 
multiple, mandatory steps that remove or inactivate any contaminants, including 
viruses that could be present. These viral inactivation steps have proven to be 
effective at eliminating new pathogens such as West Nile Virus, which has been 
transmitted by blood transfusion but never by use of plasma products. More 
generally, over the last few decades, plasma product manufacturing technology 
has evolved, and many of the identified risks from the past have been mitigated 
or eliminated.13 
 
 10.  What is Plasma?, DONATING PLASMA, http://www.donatingplasma.org/donation/what-is-
plasma [https://perma.cc/UGR9-SER6] (last visited Feb. 18, 2018). 
 11.  Slonim et al., supra note 9, at 183. 
 12.  GRIFOLS, PLASMA: A SOURCE OF LIFE, https://www.grifolsplasma.com/en/web/plasma/about-
plasma-donation/plasma-a-source-of-life [https://perma.cc/S6EL-8ZGP] (last visited Feb. 18, 2018).  
 13.  Plasma Donation in Canada, GOV’T CAN. (Jan. 5, 2018), https://www.canada.ca/en/health-
canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/fact-
sheets/plasma-donation-canada.html [https://perma.cc/29SX-J4LH].  
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B. Plasma Collection in Canada, Australia, and the United States 
Compensation for plasma donors—specifically, for the supply of plasma to be 
used for fractionation—and the establishment of for-profit plasma centers are 
legal activities in several countries, such as the United States, Czech Republic, 
and Austria. Many other countries prohibit payments.14 A common feature of 
most countries that ban compensation is that they run a deficit of plasma for 
domestic uses; therefore, they rely on imports, most often of plasma collected in 
countries where compensation is legal because, typically, these countries have a 
surplus of available plasma.15 The different legal status of payments to donors 
around the world and the international plasma procurement and allocation 
patterns are somewhat exemplary of the challenges in defining repugnant trades 
and in determining the reasons for bans to compensation. 
In Canada, most provinces prohibit compensation to plasma donors. Ontario 
and Alberta passed legislation that prohibits compensation for plasma in 2014 
and 2017, respectively.16 In Quebec, payments to plasma donors have been illegal 
since 1994,17 and currently, British Columbia and Nova Scotia are considering 
similar legislation.18 Private plasma centers that pay donors are active in 
Saskatchewan though.19 However, there is a debate about banning compensation 
for plasma donors at the federal level.20 
Canadian Blood Services and Héma-Québec are the only organizations that 
collect plasma (and blood) for transfusion, and they do so exclusively from 
unpaid donors.21 Plasma collected from volunteers in Canada is sufficient for 
 
 14.  Slonim et al., supra note 9, at 185.  
 15.  See Blood Safety and Availability—Fact Sheet, WORLD HEALTH ORG. (June 2017), 
 http://www.who.int/mediacentre/factsheets/fs279/en/ [https://perma.cc/2SB5-J3PY]. See generally 
PLASMA FRACTIONATION REVIEW COMMITTEE, COMMONWEALTH OF AUSTRALIA, REVIEW OF 
AUSTRALIA’S PLASMA FRACTIONATION ARRANGEMENTS 69–83 (2006),  
https://www.health.gov.au/internet/main/publishing.nsf/Content/B3B4E1D741764DD2CA257BF000193
A6F/$File/plasma_FINAL%20as%20at%2030%20November%202006.pdf [https://perma.cc/4Z7H-
9VWW] (describing several countries’ processes for acquiring the necessary amount of plasma).  
 16.  Voluntary Blood Donations Act, S.A. 2017, V–5 (Can.); Voluntary Blood Donations Act, S.O. 
2014, c. 14 (Can.).  
 17.  Civil Code of Québec, CQLR c CCQ-1991 art. 25 (Can.). 
 18.  See Debates and Proceedings on Bill No. 37, Voluntary Blood Donations Act Before the House 
of Assembly of Nova Scotia, 1064–1080 (2017) (Can.) (debating the merits of the proposed bill, the 
Voluntary Blood Donations Act); Kelly Grant, Blood Agency Seeking $855-Million in Funding to Boost 
Plasma Supply, Document Reveals, GLOBE & MAIL (Aug. 14, 2017), https://beta.theglobeandmail.com/ 
news/national/blood-agency-seeking-855-million-in-funding-to-boost-plasma-supply-document-
reveals/article35980339/?ref=http://www.theglobeandmail.com& [https://perma.cc/MJ8H-F4AS]. 
 19.  See Canadian Plasma Clinic That Pays Donors $25 per Visit Opens in Saskatoon, CBC NEWS 
(Feb. 19, 2016), http://www.cbc.ca/news/canada/saskatoon/plasma-clinic-opens-saskatoon-1.3453062 
[https://perma.cc/E322-PAMU].  
 20.  The Canadian Press, NDP: Plasma Clinics That Pay Donors Should Be Banned by Federal 
Government, HUFFINGTON POST (Jan. 15, 2016), http://www.huffingtonpost.ca/2016/01/15/ndp-wants-
federal-ban-on-plasma-clinics-that-pay-donors-but-saskatchewan-oks-it_n_8992022.html 
[https://perma.cc/LJ7R-6T3H].  
 21.  See CANADIAN BLOOD SERVICES, HÉMA-QUÉBEC, https://blood.ca/en/news-tags/hema-
LACETERA_MACIS_PAGINATED (DO NOT DELETE) 5/9/2018  12:00 PM 
88 LAW AND CONTEMPORARY PROBLEMS [Vol. 81:83 
 
transfusions across the country. However, the domestic supply of plasma for the 
production of therapies and pharmaceutical products is not sufficient to meet the 
domestic demand. Imported plasma products make up for the difference.22 
In Australia, Australian Red Cross Blood Service (ARCBS) is the only 
organization that collects plasma (and blood) for transfusion and fractionation, 
and they do so exclusively from unpaid donors because payments to donors are 
not allowed. The biopharmaceutical company CSL Limited fractionates plasma 
from ARCBS donations and supplies a range of immunoglobulin, hyper-immune 
products, clotting factors and albumin, for domestic use. Similar to Canada, 
plasma collected from Australian volunteers is sufficient for blood transfusions 
in the country. However, the domestic supply of plasma for the production of 
therapies and pharmaceutical products is not sufficient to meet the domestic 
demand, so Australia must import plasma products to fulfill the medical needs of 
its patient population.23 
In contrast, plasma donors in the United States receive compensation. 
Individuals can donate a maximum of two times within a seven-day period,24 
receiving about $30 per donation.25 In the United States, the supply of plasma is 
sufficient to meet the domestic demand;26 moreover, the United States exports 
plasma to other countries, including Canada and Australia.27 For 
example, approximately 83% of immunoglobulin used in Canada is made from 
American paid plasma donors.28 Similarly, Australia imports 43% of its 
immunoglobulin from outside of Australia.29 
III 
EXPERIMENTAL DESIGN 
We conducted a survey experiment with a sample of 826 Canadian 
 
quebec [https://perma.cc/5GSN-WF7A] (last visited Feb. 18, 2018).  
 22.  Backgrounder Paper—Plasma Donations in Canada, GOV’T CAN. (June 27, 2013), 
https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-
consultations/biologics-radiopharmaceuticals-genetic-therapies/backgrounder-paper-plasma-donations-
canada.html [https://perma.cc/45BJ-J3BB].  
 23.  See NAT’L BLOOD AUTHORITY AUSTL., ANNUAL REPORT 2015–16 39 (2016) (explaining the 
National Blood Authority’s contracts with plasma suppliers to complement domestic supply when 
domestic plasma production cannot meet demand).  
 24.  21 C.F.R. § 640.65 (2017). 
 25.  See, e.g., Alexa Valiente, Mark Abdelmalek & Lauren Pearle, Why Thousands of Low-Income 
Americans “Donate” Their Blood Plasma to For-Profit Centers, ABC NEWS (Jan. 13, 2017), 
http://abcnews.go.com/US/thousands-low-income-americans-donate-blood-plasma-profit/story? 
id=44710257 [https://perma.cc/J9UZ-7ASF]. 
 26.  Slonim, et al., supra note 9, at 185.  
 27.  See Gilbert M. Gaul, The Blood Brokers—America: The OPEC of the Global Plasma 
Industry, PHILA. INQUIRER (Sep. 28, 1989), http://www.bloodbook.com/part-5.html [https://perma.cc/ 
9AMG-L83M] (“More than half the estimated 12 million liters of plasma used in medicines worldwide 
comes from the United States.”).  
 28.  CANADIAN BLOOD SERVICES, supra note 8. 
 29.  NAT’L BLOOD AUTHORITY AUSTL., supra note 23, at 33.  
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respondents recruited by ResearchNow, a market research data company. The 
recruitment protocol was such that the sample would be representative of the 
Canadian population for such features as gender, age, and geographical location. 
Figure 1 outlines the flow of the survey. All participants first read a text of 
about 320 words that included general information about plasma and plasma 
donation: what plasma is, what its medical uses are, the different ways of 
collecting plasma from donors, some basic features of the process of plasma 
fractionation and the manufacturing of plasma products, and some information 
on the quantity of plasma needed to address certain diseases. 
The survey then introduced a random-experimental component with a 2-by-
2 design. With ex-ante 50% probability, we assigned respondents to one of two 
texts. The first text provided a description of the plasma procurement and 
allocation system in Canada—we refer to this group as the “Canada text” group. 
The text explained that the majority of Canadian provinces, including the largest 
ones, prohibit compensation to donors as well as the establishment of for-profit 
plasma centers. It also included a summary of the different positions in the debate 
about legalizing compensation. Proponents of compensating plasma donors 
argue that payments would increase supply, and that there have been no 
instances of contaminated plasma from paid donors in the past twenty years. 
Among the arguments against payments were the concerns that compensation 
may hamper the voluntary system, attract donors with communicable diseases, 
and violate human dignity because certain transactions should be kept out of the 
market. Finally, the text noted that about 83% of plasma for fractionation used 
in Canada is imported from the United States, where payments to plasma donors 
are legal. 
The remaining respondents read a similar text with information about plasma 
procurement and allocation in Australia, another country that does not allow 
payments to donors (we refer to this group as the “Australia text” group). The 
information provided was specific to the Australian case, but the structure of the 
text, including information about imports from countries that allow payments 
(for example, the United States), was the same as the text about Canada. 
We then further divided the participants in each of the two groups into two 
subgroups, again with ex-ante 50% probability for each respondent. Within the 
“Canada text” group, we asked one subgroup to express their opinion about 
whether payments to plasma donors should be allowed in Canada (we refer to 
this subgroup as the “Canada text & Canada vote” group). We asked the other 
subgroup whether payments to plasma donors should be allowed in the United 
States—the “Canada text & US vote” group. Similarly, for the “Australia text” 
group, we asked one subgroup to express their opinion about whether payments 
to plasma donors should be allowed in Australia (the “Australia text & Australia 
vote” group), and we asked the other subgroup whether payments to plasma 
donors should be allowed in the United States (“Australia text & US vote” 
group). The respondents could check one of two options: “I think payments to 
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plasma donors should be allowed in Canada/Australia/the United States,” or “I 
think payments to plasma donors should not be allowed in Canada/Australia/the 
United States.” 
Because all respondents were Canadian residents, this design allowed us to 
assess both the support for compensation to plasma donors in their own country 
and the support for payments in other countries. We chose Australia as one of 
these other countries because, in addition to having cultural similarities and a 
level of economic development comparable to Canada’s, compensation to plasma 
donors is illegal in Australia, and it imports plasma for fractionation just like 
Canada. We also included the United States because compensation is legal in the 
United States and the country runs a vast supply surplus that allows for exports 
of plasma. Canada relies on this imported plasma. to produce a range of 
therapies. We could therefore determine whether any support or opposition to 
compensation was general or specific to the country of residence of the 
population of interest (Canadians), and whether the current legal framework in 
a country correlated with the level of agreement or aversion toward 
compensation. 
After the participants answered about their support for compensating plasma 
donors, the survey directed them to different sets of questions, according to 
whether they expressed opposition or favor, and according to the country on 
which they expressed their view. These questions contained statements that 
reported a set of reasons for being in favor of or against payments. For each of 
the listed reasons, we asked the respondents to give a rating from 0 to 100 to 
indicate how important that reason was in motivating their position. 
For the “Canada text & Canada vote” and the “Australia text & Australia 
vote” groups, we proposed the following three reasons to those who opposed 
payments to plasma donors: 
• “It is immoral to provide monetary payments to plasma donors in 
Canada/Australia— donations should be unpaid” 
• “Monetary payments may attract donors who carry transmittable 
diseases” 
• “Increasing domestic supply of plasma is not a priority, 
Canada/Australia can rely on imports” 
For those who did not support payments in the United States (respondents in 
the “Canada text & US vote” or “Australia text & US vote” groups), we replaced 
the third statement above, which is not applicable to the United States because 
the United States does not rely on imports, with the following: 
• “The US produces more plasma than their domestic needs, so paying 
plasma donors is unnecessary” 
For the respondents in the “Canada text & Canada vote” and the “Australia 
text & Australia vote” groups who expressed favor towards payments to plasma 
donors, we presented the following reasons, again asking the respondents to rate 
them from 0 to 100 depending on how important each statement was in 
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motivating them to be in favor of payments: 
• “It is morally appropriate to provide monetary payments to plasma 
donors in Canada/Australia—they incur costs in terms of time spent 
donating and physical discomfort to supply a valuable resource” 
• “Monetary payments to plasma donors would increase the availability 
of domestic plasma and reduce Canada’s/Australia’s dependence on 
other countries” 
• “Plasma donors receive monetary payments in some other countries, 
such as the United States, therefore they should be paid also in 
Canada/Australia” 
Finally, we provided a list of five reasons to participants in the “Canada text 
& US vote” and “Australia text & US vote” groups who favored compensating 
plasma donors: 
• “It is morally appropriate to provide monetary payments to plasma 
donors in the United States—they incur costs in terms of time spent 
donating and physical discomfort to supply a valuable resource” 
• “Monetary payments to plasma donors increase the availability of 
domestic plasma and ensure that the US does not depend on other 
countries” 
• “Some countries, such as Canada/Australia, rely on imported plasma 
from paid donors in the US” 
• “Plasma donors receive monetary payments in some other countries, 
therefore they should be paid also in the United States” 
• “It is currently legal to pay plasma donors in the US, so things should 
stay as they are” 
We chose these motives to encompass some of the main arguments that recur 
frequently in the debate about the legalization of compensation in Canada and 
elsewhere: moral considerations, concerns about the safety of plasma donated by 
paid donors, and the effects of compensation on domestic supply. Because 
payments are already legal in the United States, we modified the statements 
accordingly, and also added some statements that were specific to the U.S. case. 
We then proposed an additional question only to the respondents who had 
expressed opposition to payments in the form of a hypothetical scenario. 
Participants expressed their favor or opposition to the following statement: “If 
there was a shortage of plasma (i.e., the domestic supply plus the imports were 
not sufficient to satisfy [Canada’s/Australia’s/the US’] need for plasma), then I 
would consider supporting the introduction of monetary payments to plasma 
donors in Canada/Australia/the US.” The reason for having this additional 
question was to collect more evidence on the underlying motives for opposing 
payments; a disagreement with the hypothetical statement above would indicate 
a strong form of opposition, one that reflects deontological preferences and thus 
is not amenable, for example, to making trade-offs between different values or 
objectives. Conversely, an agreement with the statements would indicate that 
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although the respondent currently opposes payments to plasma donors, her 
preferences are more consequentialist, which implies that she is willing to make 
trade-offs between moral arguments and supply considerations. 
The last part of the survey, common to all respondents, included a series of 
socio-demographic questions. We asked participants to report their age, gender, 
ethnicity, religious beliefs, household income, education level, marital status, job 
market status, geographical area of residence within Canada, whether they had 
children, their views about social and economic issues, and whether they had 
volunteered or donated to charity in the previous two years. 
 
Figure 1: Experimental design flow. 
 
 
 
IV 
DATA AND RESULTS 
A. Sample and Balance Checks 
Table 1 reports some summary features of the 826 respondents. Consistent 
with our design, the sample is reasonably representative of the distributions by 
gender, age, ethnicity, geographic region, religious attitude, education, work 
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status, family status, income, and political orientation of the Canadian 
population. To check whether the sample was well-balanced across the four 
experimental conditions, we estimated a multinomial logit regression of the four 
treatment conditions on indicators for various socio-demographic features; we 
found that the participants’ characteristics are unrelated to the treatment to 
which the participants were assigned (p > chi2 = 0.957). 
Table 1: Descriptive statistics. 
This table reports the distribution of the socio-demographic characteristics of 
the 826 survey respondents. 
 
B. Results 
1. Result 1: The vast majority of respondents support the legalization of 
payments for plasma donors. 
Figure 2 reports the attitudes of the respondents toward legalizing payments 
for plasma donors. Each column represents the share of participants who 
expressed support for legal payments in each of the four experimental conditions. 
The main finding is that the large majority of respondents are in favor of 
legalizing payments to plasma donors. We estimate that 72.6% of Canadians are 
in favor of compensating plasma donors in Canada (95% c.i. 66.4%–78.8%), 
78.7% (95% c.i. 73.5%–84%) are in favor of compensating plasma donors in 
N. of respondents 826
Women 52.2% College degree 50.4%
Age 18-34 27.8% Employed 53.9%
Age 35-54 38.5% Retired 21.2%
Age 55+ 33.7%
Caucasian/White 74.2% Married 53.1%
East Asian 9.3% With children 53.1%
Other 16.5% Income > $50K 69.2%
Atlantic 7.4% Liberal on social issues 43.5%
Ontario 37.9% Conservative on social issues 18.1%
Quebec 22.0% Liberal on economic issues 33.7%
West 32.8% Conservative on economic issues 23.4%
Atheist 25.6% Volunteer/donates to charity 74.3%
Christan 54.9%
Jewish 3.0%
Muslim 13.8%
Other 2.7%
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Australia, and 76.4% (95% c.i. 72.1%–80.6%) are in favor of paying donors in 
the United States (combining the data from respondents who were given 
information about the demand and supply of plasma in Canada and those who 
were given information about Australia). The first-order implication of these 
results is that a representative sample of Canadians widely supports payments to 
plasma donors. The differences in support rates for different countries are 
relatively small and only marginally statistically significant when comparing 
Canada and Australia (one-tailed t test: p=0.07, two-tailed t test: p=0.14). The 
stronger support for payments in the U.S. may suggest that respondents display 
some form of “NIMBY-ism” whereby people enjoy the benefit of a given 
transaction but do not want to carry the ethical costs of it. The higher support for 
payments in Australia may suggest some moral relativism, meaning individuals 
might be more in favor of allowing morally contentious activities if they occur 
farther away. However, the small differences described above suggest that these 
mechanisms play only a minor role, if any at all. 
2. Figure 2: Support for compensation to plasma donors. 
The figure reports the percentage of respondents in each condition who 
expressed support for legalizing compensation for plasma donors. Error bars 
represent 95% confidence intervals (±1.96 * s.e.). 
 
 
 
 Table 2 reports estimates from Ordinary Least Squares regression models 
where the outcome variable is a binary indicator for support for plasma donor 
payments. Estimates in the first column are from a model that included only the 
indicators for the treatment conditions (as such, these estimates coincide with the 
statistics reported in Figure 1). The estimates in the second column are from a 
model that includes controls for the individual characteristics listed in Table 1. 
Consistent with the random assignment (and the balance of the sample as 
discussed above), the inclusion of these additional controls did not meaningfully 
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change the estimates of the coefficients on the treatment indicators. Moreover, 
none of the estimates of the parameters on the indicators for the various 
individual characteristics is statistically significant at the 5% level or less. This 
implies that the support rates for compensating plasma donors are very similar 
across the main socio-demographic categories of the Canadian population. 
3. Table 2: Support for payments to plasma donors—regression analysis. 
This table reports estimates from Ordinary Least Squares regressions. The 
dependent variable is equal to one if the respondent expressed support for 
plasma donor payments and zero otherwise. The main explanatory variables of 
interest are indicators for the experimental conditions. Column (2) also includes 
control variables. The omitted treatment indicator (represented by the constant 
in column (1)) is “Canada text & Canada vote”; the omitted age category is Age 
55+; the omitted region category is Atlantic; the omitted religion is Jewish. 
Standard errors are in parentheses (** p<0.01, * p<0.05, + p<0.1). 
 
 
(continues on next page)  
Outcome variable:
Explanatory variables: (1) (2)
Canada text & US vote 0.029 0.035
(0.045) (0.045)
Australia text & Australia vote 0.061 0.062
(0.041) (0.042)
Australia text & US vote -0.044 -0.053
(0.060) (0.061)
Age 18-34 0.044
(0.054)
Age 18-54 -0.017
(0.047)
Woman -0.051
(0.031)
East Asian -0.108+
(0.065)
White -0.012
(0.043)
Supports payments
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(continued from previous page) 
 
4. Result 2: Respondents who oppose compensation for plasma donors are 
mainly concerned about moral issues and the safety of plasma coming from paid 
donors. 
Figure 3 shows cumulative distribution functions of the ratings assigned by 
respondents who opposed paying plasma donors to the set of motives described 
in the previous section. For each line, a given point (x on the horizontal axis, y on 
Ontario -0.041
(0.060)
Quebec -0.057
(0.062)
West -0.010
(0.059)
Married -0.037
(0.036)
With children 0.042
(0.036)
Atheist/agnostic -0.069
(0.084)
Christian -0.051
(0.080)
Muslim -0.163+
(0.091)
Other -0.191
(0.126)
College degree 0.033
(0.033)
Employed 0.015
(0.039)
Retired -0.046
(0.058)
Income > $50K -0.053
(0.036)
Liberal on social issues 0.027
(0.043)
Conservative on social issues -0.017
(0.056)
Liberal on economic issues 0.002
(0.044)
Conservative on economic issues 0.012
(0.050)
Volunteer/donates to charity 0.030
(0.035)
Constant 0.726** 0.855**
(0.032) (0.130)
Observations 826 824
R-squared 0.003 0.032
Adjusted R-squared -0.000744 0.000817
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the vertical axis) indicates the share y of respondents who rated a particular 
motive x or less. Among respondents who expressed opposition to payments in 
Australia and Canada, there was a similar distribution of relevance given to 
morality and safety concerns. The average ratings for the concerns about morality 
and safety were, respectively, 69.2 and 68.4 for Canada, and 72.6 and 68.9 for 
Australia. As mentioned above, organizations and authorities that source plasma 
from countries where donors receive compensation consider the imported 
plasma to be as safe as the plasma obtained domestically. However, our results 
indicate a widespread perception among Canadians that paid plasma poses a 
health threat. At the individual level and especially for those who expressed 
opposition about paying donors in Canada, there is a strong positive correlation 
between the concerns for morality and safety (correlation coefficient = 0.54, 
significant at the 5% level). Conversely, the possibility for a country to rely on 
imported plasma was a much less important reason for the respondents’ 
opposition to allowing payments in that country. The average rating was 35.6 
among respondents opposed to paid donors in Canada, and 46.4 among those 
opposed to paid donors in Australia (two-sided p-value for difference in means 
= 0.06; p-value from Kolmogorov-Smirnov test for differences in distributions = 
0.053). A possible interpretation of this difference is that Canadians might be 
reluctant to reveal that they oppose payments to domestic plasma donors because 
they know that their country can rely on imported plasma from the United States, 
whereas they might be more likely to reveal this belief when referring to another 
country. The respondents who were against compensating donors in the United 
States rated concerns for morality and safety of the collected plasma very 
similarly to respondents who opposed payments in Canada and Australia. The 
ratings for these concerns were also similar to the ratings for a third motive that 
we proposed to these respondents, namely that payments are not needed because 
the country already runs a supply surplus. 
5. Figure 3: Ratings of reasons against compensation. 
The graphs below report cumulative distribution functions of the ratings 
(between 0 and 100) that respondents opposed to legalizing compensation to 
plasma donors gave to three reasons: “It is immoral to provide monetary 
payments to plasma donors in Canada/Australia/United States—donations 
should be unpaid” (labeled “Immoral” in the graphs); “Monetary payments may 
attract donors who carry transmittable diseases” (labeled “Diseases”); 
“Increasing the domestic supply of plasma is not a priority, Canada/Australia can 
rely on imports” (labeled “Can rely on imports”); and, “The US produces more 
plasma than their domestic needs, so paying plasma donors is unnecessary” 
(labeled “No need, supply is plentiful”). 
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Canada text & Canada vote 
 
 
Australia text & Australia vote 
 
 
Canada text & US vote 
 
 
Australia text & US vote 
 
 
6. Result 3: Respondents who are in favor of payments to plasma donors place 
great importance on guaranteeing a robust domestic supply of plasma. 
Figure 4 presents cumulative distribution functions of the ratings assigned by 
respondents who favored paying plasma donors to the set of motives described 
in the previous section. The three motives (labeled “Moral,” “Domestic supply,” 
and “Paid elsewhere” in the graphs) all received high ratings and were strongly 
correlated at the individual respondent level. Securing a higher domestic supply 
was significantly more important than the other reasons, suggesting that 
respondents who are in favor of paying plasma donors might be characterized as 
having more consequentialist (outcome-oriented) views. The respondents who 
expressed support for the paid-donor system in the United States gave similar 
ratings to all of the motives they were asked to consider. Again, the importance 
of guaranteeing a sufficient domestic supply was the reason that received the 
highest ratings. 
7. Figure 4: Rating of reasons for compensation. 
The graphs below report cumulative distribution functions of the ratings 
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(between 0 and 100) that respondents in favor of compensation to plasma donors 
gave to the following reasons: “It is morally appropriate to provide monetary 
payments to plasma donors in Canada (Australia, the United [S]tates)—they 
incur costs in terms of time spent donating and physical discomfort to supply a 
valuable resource” (labeled “Moral” in the graphs); “Monetary payments to 
plasma donors would increase the availability of domestic plasma and reduce 
Canada’s/Australia’s dependence on other countries,” or, for the United States, 
“Monetary payments to plasma donors increase the availability of domestic 
plasma and ensure that the US does not depend on other countries” (labeled 
“Domestic supply”); “Plasma donors receive monetary payments in some other 
countries, therefore they should be paid also in Canada/Australia/the United 
States” (labeled “Paid elsewhere”); “Some countries, such as Canada/Australia, 
rely on imported plasma from paid donors in the US” (labeled “Other countries 
rely on US imports”); and, “It is currently legal to pay plasma donors in the US, 
so things should stay as they are” (labeled “Status quo”). 
 
Canada text & Canada vote 
 
 
Australia text & Australia vote
 
 
Canada text & US vote
 
Australia text & US vote
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8. Result 4: About half of the respondents who opposed payments would 
reconsider their position in the case of a supply shortage. 
As shown in Figure 5, between 43.5% (Canada or Australia text & US vote) 
and 51% (Australia text & Australia vote) of the participants who opposed 
payments reported that they would be willing to support compensating plasma 
donors in the case of a supply shortage, that is, if the domestic supply plus imports 
were insufficient to meet domestic demand. The differences between the 
treatment groups, however, are not statistically significant both because the 
differences are not large and because of the relatively small sample sizes of the 
four groups. These positions were similar across the various socio-demographic 
characteristics of our respondents, as shown by the regression estimates in Table 
3. 
9. Figure 5: Percentage of respondents against plasma donor compensation 
who would reconsider their position in the case of a supply shortage. 
The figure reports the shares of respondents who indicated opposition to legal 
compensation for plasma donors, but who responded that they would consider 
supporting payments in the case of a supply shortage. Error bars represent 95% 
confidence intervals (±1.96 * s.e.). 
 
 
10. Table 3: Support for payments in case of supply shortage—regression 
analysis. 
This table reports the estimates from an Ordinary Least Squares regression. The 
dependent variable is equal to one if the respondent answered, “Yes I would be in favor 
of paying plasma donors in case of a supply shortage”—that is, if the domestic supply plus 
imports were insufficient to meet the domestic needs. The main explanatory variables of 
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interest are indicators for the experimental conditions. Column (2) also includes control 
variables. The omitted treatment indicator (represented by the constant in column (1)) is 
“Canada text & Canada vote”; the omitted age category is Age 55+; the omitted region 
category is Quebec; the omitted religion is Other. Standard errors are in parentheses (** 
p<0.01, * p<0.05, + p<0.1). 
 
(continues on next page)   
Outcome variable: Support if shortage
Explanatory variables:
Canada text & US vote -0.105
(0.106)
Australia text & Australia vote 0.024
(0.099)
Australia text & US vote 0.008
(0.145)
Age 18-34 0.240+
(0.125)
Age 18-54 0.078
(0.111)
Woman -0.084
(0.080)
East Asian -0.124
(0.143)
White -0.106
(0.113)
Atlantic 0.183
(0.171)
Ontario 0.005
(0.098)
West 0.099
(0.102)
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(continues from previous page) 
 
 
Married -0.159+
(0.085)
With children 0.028
(0.090)
Atheist/agnostic -0.060
(0.215)
Christian -0.121
(0.212)
Jewish -0.213
(0.329)
Muslim 0.064
(0.219)
College degree 0.011
(0.081)
Employed -0.082
(0.099)
Retired 0.030
(0.138)
Income > $50K -0.024
(0.090)
Liberal on social issues 0.053
(0.123)
Conservative on social issues -0.272+
(0.155)
Liberal on economic issues 0.074
(0.126)
Conservative on economic issues 0.275+
(0.142)
Volunteer/donates to charity 0.275**
(0.085)
Constant 0.438+
(0.256)
Observations 195
R-squared 0.175
Adjusted R-squared 0.0475
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As a further attempt to study whether those who were willing to reconsider 
their opposition to payments held different views and values towards 
compensation, we compared the ratings they attributed to the various reasons 
proposed (Figure 6). Overall, and both for respondents who opposed payments 
in Canada and in Australia, those who would not support compensation, even in 
case of plasma supply shortage, gave higher importance to moral and safety 
concerns. 
11. Figure 6: Ratings of reasons for being against payments and whether 
respondents would reconsider their position in case of supply shortage. 
The graphs below report cumulative distribution functions of the ratings that 
respondents who were against compensating plasma donors gave to the three 
motives the survey asked them to rate (between 0 and 100), separately for those 
who would support payments in case of supply shortage and those who would 
still oppose payments even in case of a shortage. “Immoral” stands for the survey 
statement: “It is immoral to provide monetary payments to plasma donors in 
Canada/Australia/United States—donations should be unpaid.” “Diseases” 
stands for: “Monetary payments may attract donors who carry transmittable 
diseases.” “Can rely on imports” (only for Canada and Australia) stands for: 
“Increasing domestic supply of plasma is not a priority, Canada/Australia can rely 
on imports.” 
 
Immoral (N=190) 
 
Diseases (N=187)
 
Can rely on imports (N=100)
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V 
CONCLUSION 
The first-order finding from our study is that the vast majority of respondents 
expressed support for compensation to plasma donors. We found no evidence of 
widespread societal opposition to payments to plasma donors. Although the 
support of our Canadian respondents was higher for paying plasma donors in 
Australia and the United States than in Canada, the differences were small, 
suggesting a weak role for “moral NIMBY-ism” or moral relativism in explaining 
the findings. Moreover, there were no differences across the different categories 
of respondents—for example, by gender, religious attitude, geographical 
location, age, education, or political orientation. This suggests that attitudes 
towards payments to plasma donors reflect deep-seated individual traits that 
observable socio-demographics are unable to predict and that go beyond, for 
example, gender differences or left–right political preference divides. 
Second, moral concerns were the highest-rated reason that respondents gave 
for being against payments. Respondents also gave high importance to concerns 
for the safety of plasma supplied by compensated donors, although most of the 
plasma in Canada does come from compensated American donors. Furthermore, 
the organizations in charge of the procurement and allocation of plasma have 
repeatedly assured (and proven) that plasma from American paid donors is as 
safe as plasma from Canadian unpaid donors. Because safety concerns are 
unjustified by the evidence, appropriate informational campaigns could help 
dispel this misconception. More opportunistic considerations, such as the fact 
that the supply surplus from the United States allows Canada to rely on imports 
without the need to pay donors domestically, had a much less important role as 
motivation for opposing compensation. 
In contrast, among those in favor of legalizing compensation for donors (in 
Canada as well as in Australia), the highest-rated motive was to guarantee a 
higher domestic supply. The majority of the respondents who were in favor of 
legalizing compensation also agreed that compensation would not run against 
mainstream Canadian moral and societal values. Most Canadians, therefore, 
seem to espouse a consequentialist view to issues related to the procurement of 
plasma. 
Because roughly half of those who declared to be against payments reported 
that they would reconsider their position if the domestic supply and imports were 
insufficient to meet domestic demand, we may conclude that up to about 85% of 
our Canadian respondents share a consequentialist view regarding the regulation 
of the demand and supply of plasma. Conversely, the remaining approximately 
15% of respondents who continued to oppose payment even when faced with a 
hypothetical supply shortage can be characterized by deontological preferences: 
prohibiting payments is a value of a higher order than guaranteeing an adequate 
supply of plasma. The finding that the attitudes of Canadians toward 
compensating plasma donors are very similar regardless of whether donors are in 
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Canada or elsewhere is consistent with the attitudes reported in the survey and 
the stated motivations, representing general moral values of the respondents. 
In addition to advancing our understanding of individuals’ attitudes and social 
support for morally contentious transactions, our study contributes to the current 
debate in Canada and elsewhere about whether payments to plasma donors 
should be legal. The growing demand for plasma, especially for the manufacture 
of therapeutic products, creates an urgent need for a careful discussion on the 
relative merits of different procurement and allocation systems in a way that 
addresses the increasing demand while abiding by the prevailing moral values in 
a society. We hope that the evidence from this study will provide insights to 
address these questions of relevance for public health. 
More generally, we see our study as supporting a broader philosophy about 
the role of research in informing societal debates and choices. Many political 
decisions are thorny because, for example, they involve conflicts between 
competing societal and moral values and interests that policymakers are called to 
resolve. Examples include legislation about gestational surrogacy; physician-
assisted death; same-sex unions; the donation of organs, blood, plasma and 
gametes; prostitution; and the treatment of animals in farms, among others. 
Other political questions, ranging from redistribution policies to the treatment of 
migrants and refugees, also touch upon rooted beliefs and customs of individuals 
and societies. In these and similar cases, our view is that a primary role for 
empirical social scientists is to devise rigorous methodologies to elicit the actual 
beliefs of the population of interest. Because the choices to be considered often 
concern activities that are not legal or policies still to be implemented, surveys of 
individual opinions are often based on hypothetical scenarios and, as such, 
require some care in interpreting the results. Notwithstanding this caveat, with 
proper methodological approaches it is possible to provide reliable evidence 
about the prevailing opinions on complex, morally-charged topics. Of course, in 
a representative democracy, it is a prerogative of policymakers to not follow the 
prevailing positions of a population. However, we believe that reliable evidence 
of these opinions should be, whenever available, considered in the political 
decision process. 
